Exact FDA event identifier

Event 83580

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: August 16, 2019
Product types: Drug
Classifications: Class II
Statuses: Terminated
Recalling firm wording: SCA Pharmaceuticals, LLC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Ketamine 50 mg/5 mL in 0.9% Sodium Chloride Injection for IV or IM Use (concentration = 10 mg/mL), 6 mL Syringe, Rx Only, SCA Pharmaceuticals, Windsor, CT 06095, NDC 70004-0430-09.

D-1843-2019

Recall number: D-1843-2019
Initiated: August 16, 2019
Classification: Class II
Status: Terminated
Recalling firm: SCA Pharmaceuticals, LLC
Quantity: 922 syringes

App-derived interpretation

Sterility assurance reason.sterility_assurance · v1.0.0

Lack of Assurance of Sterility

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Lack of Assurance of Sterility.

Code information

Lot #: 1219010961, Exp. 10/24/2019

Distribution pattern

Nationwide in the U.S.